{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:03:30Z","timestamp":1789499010040,"version":"build-2803163510"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"26","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6,26]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Fourth-generation assays detecting human immunodeficiency virus (HIV)-1\/2 antibodies and the p24 antigen are widely used for HIV screening; however, false-positive (FP) results remain a limitation, particularly in low-prevalence settings. This study aimed to identify factors associated with false positivity in the Elecsys HIV combi PT assay and to evaluate the relationship between cutoff index (COI) values and confirmed HIV infection. A total of 36,046 individuals were screened using the Elecsys HIV combi PT assay. Serum samples were analyzed for anti-HIV antibodies and p24 antigen using a fourth-generation electrochemiluminescence immunoassay. Repeatedly reactive samples were referred to a reference laboratory and evaluated according to the national HIV diagnostic algorithm, including VIDAS HIV-1\/2 DUO Ultra, HIV-1\/2 antibody differentiation assay, and HIV-1 ribonucleic acid polymerase chain reaction testing when required. Receiver operating characteristic curve analysis was performed to assess the ability of the COI values to differentiate true-positive results from presumed FP results. Presumed FP cases and nonreactive controls were evaluated to identify factors associated with false positivity. Of the screened individuals, 122 (0.33%) had repeatedly reactive screening results. Among these, 24 were confirmed HIV-positive and 98 were classified as presumed FP, corresponding to an overall false-positivity rate of 0.27%. Presumed FP results were moderately associated with concurrent infection or recent vaccination within the preceding 6 months (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.05). The median COI values were significantly higher in the true-positive cases than in the presumed FP cases (458.9 and 1.75, respectively;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.05). Receiver operating characteristic analysis suggested that COI values demonstrated discriminatory performance within the study population, with an assay- and population-specific cutoff value of 72.085 identified. Our findings indicate that COI values may serve as a supportive laboratory parameter for interpreting screening reactivity, particularly in low-prevalence settings; however, confirmatory testing should remain essential for diagnosis.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000049484","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T18:00:28Z","timestamp":1782496828000},"page":"e49484","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["False-positive results in the Elecsys HIV combi PT assay: A retrospective analysis of contributing factors and cutoff index values"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2526-397X","authenticated-orcid":false,"given":"Mediha","family":"Ugur","sequence":"first","affiliation":[{"name":"Department of Medical Microbiology, Giresun University Faculty of Medicine, Giresun, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet Melih","family":"Sahin","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology and Infectious Diseases, Giresun University Faculty of Medicine, Giresun, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esin","family":"Avci","sequence":"additional","affiliation":[{"name":"Department of Statistics, Giresun University Faculty of Science and Letters, Giresun, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260915","doi-asserted-by":"crossref","first-page":"e0180071","DOI":"10.1371\/journal.pone.0180071","article-title":"The characteristics of screening and confirmatory test results for HIV in Xi\u2019an, China.","volume":"12","author":"Wang","year":"2017","journal-title":"PLoS One"},{"key":"R3-20260915","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5152\/kd.2018.04","article-title":"HIV infection in Turkey: how close are we to the target?","volume":"31","author":"G\u00f6kengin","year":"2018","journal-title":"Klimik J"},{"key":"R6-20260915","doi-asserted-by":"crossref","first-page":"5097189","DOI":"10.1155\/2022\/5097189","article-title":"An analysis of predictive sample-to-cutoff index for HIV infection confirmation using Elecsys\u00ae HIV combi PT assay.","volume":"2022","author":"Xia","year":"2022","journal-title":"Int J Clin Pract"},{"key":"R8-20260915","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5578\/mb.20028","article-title":"Experience of the national HIV-AIDS reference center of Turkey, in the transition to the new HIV diagnostic algorithm; comparative analysis of line-immunoassay test and Bio-Rad Geenius\u2122 HIV-1\/2 antibody confirmatory assay.","volume":"55","author":"Demir","year":"2021","journal-title":"Mikrobiyol Bul"},{"key":"R9-20260915","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1186\/s12879-023-08891-9","article-title":"Using signal-to-cutoff ratios of HIV screening assay to predict HIV infection.","volume":"23","author":"Guo","year":"2023","journal-title":"BMC Infect Dis"},{"key":"R10-20260915","doi-asserted-by":"crossref","first-page":"877643","DOI":"10.3389\/fcimb.2022.877643","article-title":"Clinical application evaluation of Elecsys\u00ae HIV duo assay in Southwest China.","volume":"12","author":"Yang","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"R11-20260915","doi-asserted-by":"crossref","first-page":"108556","DOI":"10.1016\/j.intimp.2022.108556","article-title":"Analysis of the characteristics of patients with false-positive HIV screening assay results.","volume":"105","author":"Lin","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"R12-20260915","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.3233\/thc-150938","article-title":"Systemic lupus erythematosus patient with false positive results of antibody to HIV: a case report and a comprehensive literature review.","volume":"23","author":"Jian","year":"2015","journal-title":"Technol Health Care"},{"key":"R13-20260915","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.2147\/IDR.S481681","article-title":"Positive HIV screening test in a patient with rapidly progressive interstitial lung disease: a case report.","volume":"17","author":"Chen","year":"2024","journal-title":"Infect Drug Resist"},{"key":"R14-20260915","doi-asserted-by":"crossref","first-page":"e23503","DOI":"10.1002\/jcla.23503","article-title":"The evaluation of low cut-off index values of Elecsys\u00ae HIV combi PT assay in predicting false-positive results.","volume":"34","author":"Tang","year":"2020","journal-title":"J Clin Lab Anal"},{"key":"R15-20260915","first-page":"e10884","article-title":"A case of false-positive HIV test in a patient with newly diagnosed Hodgkin lymphoma and literature review.","volume":"12","author":"Bukhari","year":"2020","journal-title":"Cureus"},{"key":"R16-20260915","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/QAD.0000000000003507","article-title":"Increased risk of false-positive HIV ELISA results after COVID-19.","volume":"37","author":"Alfie","year":"2023","journal-title":"AIDS"},{"key":"R17-20260915","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1086\/517684","article-title":"False-positive enzyme immunoassay for human immunodeficiency virus due to acute cytomegalovirus infection.","volume":"27","author":"Bronze","year":"1998","journal-title":"Clin Infect Dis"},{"key":"R18-20260915","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1001\/archfami.9.9.924","article-title":"False-positive and indeterminate human immunodeficiency virus test results in pregnant women.","volume":"9","author":"Doran","year":"2000","journal-title":"Arch Fam Med"},{"key":"R20-20260915","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/s41598-020-80047-0","article-title":"A method to alleviate false-positive results of the Elecsys HIV combi PT assay.","volume":"11","author":"Lu","year":"2021","journal-title":"Sci Rep"},{"key":"R21-20260915","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1128\/JCM.03583-14","article-title":"A signal-to-cutoff ratio in the Abbott architect HIV Ag\/Ab Combo assay that predicts subsequent confirmation of HIV-1 infection in a low-prevalence setting.","volume":"53","author":"Jensen","year":"2015","journal-title":"J Clin Microbiol"},{"key":"R22-20260915","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1007\/s10096-018-3290-y","article-title":"HIV serology signal-to-cutoff ratio as a rapid method to predict confirmation of HIV infection.","volume":"37","author":"Li","year":"2018","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R23-20260915","doi-asserted-by":"crossref","first-page":"124","DOI":"10.54453\/TMCD.2023.09327","article-title":"HBsAg, anti-HBs, anti-HCV, and anti-HIV seroprevalence among patients admitted to Kafkas University Health Research and Training Hospital.","volume":"53","author":"\u00d6zg\u00fcr","year":"2023","journal-title":"Turk Mikrobiyol Cemiy J"},{"key":"R24-20260915","first-page":"397","article-title":"HBsAg, anti-HBs, anti-HCV and anti-HIV seroprevalence among patients admitted to our hospital; 5-year retrospective data.","volume":"79","author":"Avcik\u00fc\u00e7\u00fck","year":"2022","journal-title":"Turk Bull Hyg Exp Bio"},{"key":"R25-20260915","doi-asserted-by":"crossref","first-page":"24","DOI":"10.5152\/kd.2020.05","article-title":"Confirmatory test results in patients with a reactive anti-HIV test result: 4-year data.","volume":"33","author":"Vari\u015fli","year":"2020","journal-title":"Klimik J"},{"key":"R27-20260915","first-page":"1","article-title":"Evaluation of fourth-generation ELISA assay cut-off values in the context of confirmation test results.","volume":"10","author":"Turko\u011flu","year":"2021","journal-title":"Abant Med J"},{"key":"R28-20260915","doi-asserted-by":"crossref","first-page":"27","DOI":"10.34084\/bshr.551035","article-title":"Evaluation of patients with anti-HIV \u00bd reactivity with confirmation test results.","volume":"3","author":"Toptan","year":"2019","journal-title":"J Biotechnol Strat Health Res"},{"key":"R29-20260915","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jcv.2017.04.014","article-title":"Relevance of cutoff on a 4th generation ELISA performance in the false positive rate during HIV diagnostic in a low HIV prevalence setting.","volume":"92","author":"Chacon","year":"2017","journal-title":"J Clin Virol"},{"key":"R30-20260915","doi-asserted-by":"crossref","first-page":"4","DOI":"10.7754\/Clin.Lab.2021.210308","article-title":"The optimal cutoff value to predict HIV infection using the architect HIV Ag\/Ab combo.","volume":"68","author":"Zhang","year":"2022","journal-title":"Clin Lab"},{"key":"R31-20260915","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/cid\/ciad264","article-title":"Increase in false-positive fourth-generation human immunodeficiency virus tests in patients with coronavirus disease 2019.","volume":"77","author":"Gudipati","year":"2023","journal-title":"Clin Infect Dis"},{"key":"R32-20260915","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12981-015-0086-3","article-title":"Spectrum of false positivity for the fourth generation human immunodeficiency virus diagnostic tests.","volume":"13","author":"Liu","year":"2016","journal-title":"AIDS Res Ther"},{"key":"R33-20260915","first-page":"e34096","article-title":"False-positive human immunodeficiency virus results in COVID-19 patients.","volume":"15","author":"Hakobyan","year":"2023","journal-title":"Cureus"},{"key":"R34-20260915","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/lt.23635","article-title":"False positivity for the human immunodeficiency virus antibody after influenza vaccination in a living donor for liver transplantation.","volume":"19","author":"Eguchi","year":"2013","journal-title":"Liver Transpl"},{"key":"R35-20260915","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1056\/NEJMc053417","article-title":"Influenza vaccination and false positive HIV results.","volume":"354","author":"Erickson","year":"2006","journal-title":"N Engl J Med"},{"key":"R36-20260915","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1001\/jama.1992.03490080089031","article-title":"Multiple false-positive serologic tests for HIV, HTLV-1, and hepatitis C following isnfluenza vaccination, 1991.","volume":"268","author":"Kenzie","year":"1992","journal-title":"JAMA"},{"key":"R37-20260915","first-page":"191","article-title":"Donor follow-up of influenza vaccine-related multiple viral enzyme immunoassay reactivity.","volume":"67","author":"Arnold","year":"1994","journal-title":"Vox Sang"},{"key":"R38-20260915","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1097\/AOG.0000000000005726","article-title":"False-positive human immunodeficiency virus-1 test results with rapid seroreversion after third-trimester Tdap booster vaccination.","volume":"144","author":"Yu","year":"2024","journal-title":"Obstet Gynecol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049484","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T18:09:19Z","timestamp":1789495759000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":32,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000049484","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"assertion":[{"value":"2025-12-25","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-09","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}